Search clinical trials for: BI 1060469, iFF, Test

Total 117 results

Boehringer Ingelheim

Completed

Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

Asthma

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

Healthy

Germany
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Healthy

Germany
Myanmar Oxford Clinical Research Unit
Mahidol Oxford Tropical Medicine Research Unit; Medical Action Myanmar; National... and other collaborators

Completed

Rickettsiae in Myanmar (Rickettsiae)

Rickettsiae Infections

Myanmar
Rhode Island Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents (iDOVE2)

Depressive Disorder | Violence

United States
Boehringer Ingelheim

Terminated

Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States, Germany
Patri-cia Angelica de Miranda Silva Nogueira

Completed

CPAP Versus Bi-level in Chronic Heart Failure (CHF)

Heart Failure
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

Healthy

Germany
University Hospital, Grenoble

Completed

How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study (DBS-EMOTION)

Parkinson's Disease
Samsun Education and Research Hospital

Completed

Follicular Fluid Fetuins in in Vitro Fertilization

Infertility | Infertility, Female

Turkey
Biosense Webster, Inc.

Terminated

Oral Anticoagulation Therapy Pilot Study (OAT)

Paroxysmal Atrial Fibrillation

United States, Germany, Italy, France
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

Healthy
Beckman Coulter, Inc.

Completed

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

Sepsis | Severe Sepsis | Emergency Department | Adult Disease

United States
Oslo University Hospital

Completed

Optimising FSH Dosage During in Vitro Fertilization Fertilization (IVF)

Infertility

Norway
Cancer Research UK
BioInvent International AB; Bloodwise

Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

B-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic Leukaemia

United Kingdom
University of Pennsylvania

Completed

Post-op Crowd Sourcing Health Data Via Text-messaging

Surgery | Opioid Use | Orthopedic Surgery | Neurosurgery | Acute Injuries Knee

United States
Baskent University

Completed

Previous Injury History and Performance of Male Elite Ice Hockey Players

Wounds and Injuries | Sports Physical Therapy

Turkey
Peking University Third Hospital

Completed

Internal Rotation Resistance Test at Abduction and External Rotation

Rotator Cuff Tears

China
Enrique Quintero

Completed

Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy (COLONFAM)

Colorectal Cancer

Spain
University of Miami
National Institute on Drug Abuse (NIDA); University of California, San Francisco

Completed

Rapid HIV Testing and Counseling in Drug Abuse Treatment

Substance-Related Disorders

United States
Sohag University

Not yet recruiting

Prevelance Of Cutaneous Disorders Among Patients With Heamatologic Malignancies

Dermatologic Disorders With Heamatologic Malignancies Patients

Egypt
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Healthy

Germany
Imugen
American National Red Cross; Memorial Blood Centers, Minnesota; Rhode Island...

Completed

Babesia Testing in Blood Donors

Transfusion Transmitted Babesiosis

United States
Cedars-Sinai Medical Center

Completed

Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

Type 2 Diabetes Mellitus | Acromegaly

United States
Boehringer Ingelheim

Completed

Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers

Healthy
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Lymphoma, B-Cell

Japan
Boehringer Ingelheim

Active, not recruiting

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Solid Tumors, KRAS Mutation

Spain, United Kingdom, United States, Belgium
Boehringer Ingelheim

Recruiting

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Obesity | Overweight

Germany
Boehringer Ingelheim

Completed

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

Lymphoma, Large B-Cell, Diffuse

Spain, Italy, Belgium
Cairo University

Completed

Prevalence of Subacromial Impingement Among Egyptian Swimmers

Subacromial Impingement Syndrome

Egypt
Boehringer Ingelheim

Active, not recruiting

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Healthy

Germany
Hospices Civils de Lyon

Recruiting

Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia (MOTOLANG-AVC)

Stroke | Aphasia

France
InflaRx GmbH

Completed

Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia (PANAMO)

Severe COVID-19 Pneumonia

Belgium, Brazil, France, Germany, Mexico, Netherlands, Peru, Russian Federation, South Africa
Pfizer

Completed

Canadian Pegvisomant Compassionate Study In Acromegalic Patients

Acromegaly

Canada
University Hospital, Angers

Unknown

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD (TRAFIC)

NAFLD
Boehringer Ingelheim

Completed

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Hepatitis C

United States, Austria, Canada, France, Germany, Romania
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Hepatitis C, Chronic

United States, Austria, Belgium, Canada, France, Germany, Japan, Portugal, Puerto Rico, Spain, Switzerland, United Kingdom
Hoffmann-La Roche

Completed

A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration

Healthy Volunteers

New Zealand, Taiwan, Australia, Hong Kong, Singapore
Saint Anselm College
Catholic Medical Center

Completed

Effectiveness of a Web-based Nursing Intervention in the Reduction of Postpartum Depression and Parenting Stress.

Depression, Postpartum

United States
Institut de Recherche en Sciences de la Sante,...

Recruiting

Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. (e-MANIC)

Antimicrobial Resistance

Burkina Faso
Boehringer Ingelheim

Recruiting

A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles Midazolam

Healthy

Belgium
Laureate Institute for Brain Research, Inc.

Not yet recruiting

Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa

Anorexia Nervosa | Body Image Disturbance | Interoception

3

Subscribe